Scotch Plains, NJ, United States of America

Gee-Hong Kuo

USPTO Granted Patents = 47 


 

Average Co-Inventor Count = 4.8

ph-index = 8

Forward Citations = 194(Granted Patents)


Company Filing History:


Years Active: 2000-2021

Loading Chart...
Loading Chart...
Loading Chart...
47 patents (USPTO):Explore Patents

Title: Insights into the Innovations of Gee-Hong Kuo

Introduction

Gee-Hong Kuo is a distinguished inventor based in Scotch Plains, NJ, with a remarkable record of 47 patents to his name. His work primarily focuses on developing pharmaceutical compounds that play a crucial role in the treatment of various metabolic disorders, particularly those related to SGLT activity.

Latest Patents

Among his recent innovations, Kuo has developed two significant patents:

1. **5-fluoro-C-(aryl or heterocyclyl)-glycoside derivatives**, aimed at serving as dual SGLT1/SGLT2 modulators. This invention includes pharmaceutical compositions that utilize these derivatives to treat disorders influenced by SGLT activity, especially dual SGLT1/2 activity.

2. **Benzocyclobutane derivatives**, which are also intended as dual SGLT1/SGLT2 modulators. Similar to his previous work, this patent focuses on the development of pharmaceutical compositions for treating disorders such as Type II diabetes mellitus, Syndrome X, and their associated complications.

Career Highlights

Gee-Hong Kuo's career includes significant contributions to the pharmaceutical industry. He has been affiliated with reputable companies such as Janssen Pharmaceutica NV and Ortho-McNeil Pharmaceutical Corporation, where he has played key roles in innovative research and development that bridges scientific discovery with patient care.

Collaborations

Throughout his career, Kuo has collaborated with several notable professionals, including Aihua Wang and Keith T. Demarest. These collaborations have fostered an environment of collective knowledge and expertise, further advancing the field of pharmaceutical sciences.

Conclusion

Gee-Hong Kuo's contributions to pharmaceutical innovation are impactful, particularly in the realm of diabetes treatment and metabolic disorders. His extensive patent portfolio reflects his dedication to improving patient outcomes through scientific advancement. His work not only showcases his innovative spirit but also influences future research and therapeutic strategies in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…